---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-006285"
form_type: "8-K"
ticker: "PMDI"
cik: "0000806517"
company_name: "PSYCHEMEDICS CORP"
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T02:30:32.042023+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Psychemedics Q3 revenue falls 9% to $5.2M; net loss narrows to $0.5M from $2.1M

## Summary
- Q3 2024 revenue $5.2M, down 9% YoY from $5.7M; nine-month revenue $15.3M, down 11%.
- Net loss narrowed to $0.5M ($0.09/share) vs $2.1M ($0.36/share) in prior-year Q3.
- Nine-month net loss $2.1M ($0.35/share) vs $3.2M ($0.56/share) in 2023.

## SEC filing metadata
- accession: 0001171843-24-006285
- form_type: 8-K
- ticker: PMDI
- cik: 0000806517
- company_name: PSYCHEMEDICS CORP
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/806517/000117184324006285/0001171843-24-006285-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/806517/000117184324006285/f8k_111224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-006285
- JSON: https://secwatch.observer/filing/0001171843-24-006285.json
- Plain text: https://secwatch.observer/filing/0001171843-24-006285.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.